Gov’t to cancel some VAT benefits for medicines and medical services
From April 2024, the turnover and import of pharmaceutical products will be subject to VAT.
Photo: Depositphotos
In Uzbekistan, some VAT benefits for medicines and medical services are being cancelled, the press service of the Tax Committee reports.
According to changes in tax and budget policy for the next year, from April 1, 2024, VAT benefits on the turnover and import of pharmaceutical products will cease to apply.
VAT will be charged on sales of:
• medical services;
• veterinary services;
• medicines;
• veterinary medicines, medical and veterinary products.
In addition, VAT will be applied to the import of medicines, veterinary medicines, medical and veterinary products, as well as raw materials.
Also, from January 1, 2024, the period of guaranteed purchase of pharmaceutical products increases from the previous 3 to 10 years. Medicines subject to localization are subject to government procurement.
Related News
12:08 / 16.12.2025
Tax Committee releases 10-month tax data for key industries
10:32 / 12.12.2025
Uzbekistan introduces stricter rules for e-services, imports, and VAT compliance
14:40 / 26.11.2025
Uzbekistan plans to keep core tax rates unchanged in 2026
16:22 / 20.11.2025